19
Participants
Start Date
March 26, 2018
Primary Completion Date
July 2, 2020
Study Completion Date
July 2, 2020
Idarucizumab
Intravenous
Beijing AnZhen Hospital, Beijing
Peking University First Hospital, Beijing
Cardiovascular Institute and Fu Wai Hospital, Beijing
First Affiliated Hospital of Dalian Medical University, Dalian
Shanghai First People's Hospital, Shanghai
Jiangsu Province Hospital, Nanjing, Jiangsu Province
2nd Affiliated Hosp Zhejiang University College of Medical, Hangzhou
Zhejiang Province People's Hospital, Hangzhou
The First Affiliated Hospital of Wenzhou Med College, Wenzhou
The Second Affiliated Hospital to Nanchang University, Nanchang
Guangdong Provincial People's Hospital, Guangzhou
Sun yet-sen Memorial Hospital, Sun yet-sen Univesity, Guangzhou
The First Affiliated Hospital of Xinjiang Medical University, Ürümqi
Lead Sponsor
Boehringer Ingelheim
INDUSTRY